Barish Edil to Smad4 Protein
This is a "connection" page, showing publications Barish Edil has written about Smad4 Protein.
Connection Strength
0.137
-
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):458-9.
Score: 0.113
-
Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg. 2011 Sep; 15(9):1611-7.
Score: 0.024